In RPs, IDC-P is strongly associated with adverse pathological features, including a higher grade, larger tumor volume, and greater probability of extraprostatic extension, seminal vesicle invasion, and pelvic lymph node metastasis; as well as adverse clinical outcomes, including early BCR, progression-free survival, and cancer-specific mortality following RP [34,35,36,37,38]. This evidence concerns the gene BCR and cancer.